Clinically, compared to other phenotypes, HCC patients carrying Gal-1– LC3+ CD68+ TAMs show the increased serum level of Gal-1 and worst OS and PFS rates (Figure 6). The gene discussed is MAP1LC3A; the disease is hepatocellular carcinoma.